Intus Biosciences, LLC — Form D

Intus Biosciences, LLC of FARMINGTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-16. The offering totals $3.5M, of which $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Paul J DenslowDirectorFarmington, CT
Thomas JarvieDirectorFarmington, CT
Matt WatsonDirectorFarmington, CT
Paul J DenslowExecutive OfficerFarmington, CT
Thomas JarvieExecutive OfficerFarmington, CT
Donna J GalluzzoDirectorFarmington, CT
Paul DenslowDirectorFarmington, CT
Paul DenslowExecutive OfficerFarmington, CT
Frank J MarcoDirectorFarmington, CT
Alan J MendelsonDirectorFarmington, CT
Daniel J WagnerDirectorFarmington, CT
Mark J DriscollDirectorFarmington, CT
David WurzerDirectorMystic, CT
William J McKenzieDirectorFarmington, CT
H. Mark J LunenburgDirectorFarmington, CT
David J WurzerDirectorFarmington, CT
William McKenzieDirectorFarmington, CT
H. Mark LunenburgDirectorFarmington, CT
Frank MarcoDirectorFarmington, CT
Patrick O'NeillDirectorWest Hartford, CT
Mark D DriscollDirectorFarmington, CT
Mark D DriscollExecutive OfficerFarmington, CT
Patrick J O'NeillDirectorFarmington, CT
Thomas P JarvieDirectorFarmington, DE
Thomas P JarvieExecutive OfficerFarmington, DE

Other filings by this issuer (10)

FiledFormOfferingSold
2025-05-27D$3.0M$1.1M
2024-07-16D$2.0M$2.0M
2022-07-07D$1.5M$800K
2022-02-03D$250K$250K
2021-01-08D$1.0M$330K
2020-05-27D/A$2.2M$2.2M
2019-08-12D$1.7M$885K
2017-12-28D$1.9M$1.8M
2016-05-31D$500K$500K
2016-01-25D$500K$40K

More